Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer

Autor: Wu, Yi-Long, Lu, Shun, Cheng, Ying, Zhou, Caicun, Wang, Mengzhao, Qin, Shukui, Lu, You, Zhang, Yang, Zhu, Yunzhong, Song, Xiangqun, Wang, Xin, Barraclough, Helen, Zhang, Xiaoqing, Chi, Haidong, Orlando, Mauro
Zdroj: In Lung Cancer September 2014 85(3):401-407
Databáze: ScienceDirect